Figure 1: CX-2029 Spider Plot: Phase 1 Dose Escalation Study (2-5 mg/kg)

Figure 1: CX-2029 Spider Plot: Phase 1 Dose Escalation Study (2-5 mg/kg)

* Denotes subject who is considered to be on treatment, as no End of Treatment date is in the database.

Format

PNG

Quelle:

CytomX Therapeutics Inc.

Downloads